CAS: 646-29-7; Stearate

📜氧化锌,硬脂酸 反应生成 锌,硬脂酸根
参考文献:Bead Wire For Tire,Rubber-Coated Bead Wire For Tire And Tire Using The
标题:Bead Wire For Tire,Rubber-Coated Bead Wire For Tire And Tire Using The
摘要:本发明涉及具有铜/锡沉积物的珠线,其锡含量为9至13重量%,铜含量为91至87重量%,每千克线材中的数量为0.65至0.85克.本发明还涉及用于轮胎的橡胶包覆的珠线,包括上述电镀珠线,胶层由包括100份橡胶聚合物,80至140份碳,4至10份硫,0.4至0.9份硫化促进剂,10至7份氧化锌和1至4份硬脂酸的组合物形成在珠线上,以及使用上述珠线制备的轮胎.本发明的珠线在电镀珠线和橡胶层之间具有优异的粘附性,因此使用此类珠线制备的轮胎避免了野钢丝.

专利信息

专利号:US-5859268-A
优先权日:1996-04-09
标 题:Process for the synthesis of α, β-unsaturated esters
发明人：ANGELICI ROBERT J; SHIH KUO-CHEN
权利人:UNIV IOWA STATE RES FOUND INC
摘要:The present invention provides a process for the synthesis of an α,β-unsaturated ester from a mono-olefin-ester using Fe(CO) 5 .

专利号:EP-0398783-B1
优先权日:1989-05-19
标题 :Process for the synthesis of acyl cyanides
发明人：DEVIC MICHEL; TELLIER PIERRE
权利人:ATOCHEM ELF SA
摘要:Process for the synthesis of acyl cyanides of formula: in which R denotes an alkyl, cycloalkyl or aryl radical or a heterocyclic residue, consisting in reacting acyl halides of formula: in which R has the above definition and X denotes a halogen, with alkali metal cyanides, characterised in that the reaction takes place in the presence of a product containing alkylene oxide units and in the presence of catalytic quantities of water.

专利号:US-6869973-B2
优先权日:2000-06-22
标题:Nitrosated and nitrosylated taxanes, compositions and methods of use
发明人：GARVEY DAVID S; LETTS L GORDON; LIN CHIA-EN; RICHARDSON STEWART K; WANG TIANSHENG
权利人:NITROMED INC
摘要:The present invention describes novel nitrosated and/or nitrosylated taxanes, and novel compositions comprising at least one nitrosated and/or nitrosylated taxane, and, optionally, at least one compound that donates, transfers or releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxide synthase and/or at least one therapeutic agent. The present invention also provides novel compositions comprising at least one taxane and at least one compound that donates, transfers or releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxide synthase and/or at least one therapeutic agent. The compounds and compositions of the present invention can also be bound to a matrix. The present invention also provides methods for treating or preventing cardiovascular diseases and disorders, autoimmune diseases, pathological conditions resulting from abnormal cell proliferation, polycystic kidney disease, inflammatory disease, preserving organs and/or tissues or to inhibit wound contraction, particularly the prophylactic and/or therapeutic treatment of restenosis, by administering nitrosated and/or nitrosylated taxane or parent taxanes in combination with nitric oxide donors that are capable of releasing nitric oxide or indirectly delivering or transferring nitric oxide to targeted sites under physiological conditions.

专利号:US-7384976-B2
优先权日:2001-05-02
标 题:Nebivolol and its metabolites in combination with nitric oxide donors, compositions and methods of use
发明人：GARVEY DAVID S
权利人:NITROMED INC
摘要:The invention describes novel compositions comprising nebivolol and/or at least one metabolite of nebivolol and at least one nitric oxide donor, and, optionally, at least one antioxidant or a pharmaceutically acceptable salt thereof, and/or at least one compound used to treat cardiovascular diseases or a pharmaceutically acceptable salt thereof, and/or at least one nitrosated compound used to treat cardiovascular diseases. The compounds and compositions of the invention can also be bound to a matrix. The nitric oxide donor is a compound that donates, transfers or releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxide synthase and may preferably be isosorbide dinitrate and/or isosorbide mononitrate. The antioxidant may preferably be a hydralazine compound or a pharmaceutically acceptable salt thereof. The invention also provides methods for treating and/or preventing vascular diseases characterized by nitric oxide insufficiency; and for treating and/or preventing Raynaud's syndrome; and for treating and/or preventing cardiovascular diseases or disorders.

专利号:US-2006194258-A1
优先权日:1989-06-07
标题:Polypeptide array synthesis
发明人：PIRRUNG MICHAEL C; STRYER LUBERT; FODOR STEPHEN P; READ J L
权利人:AFFYMETRIX INC
摘要:The present invention provides methods and apparatus for sequencing, fingerprinting and mapping biological macromolecules, typically biological polymers. The methods make use of a plurality of sequence specific recognition reagents which can also be used for classification of biological samples, and to characterize their sources.

专利号:US-2013089740-A1
优先权日:2010-06-29
标题:Synthesis and use of iron oleate
发明人：BURDINSKI DIRK; BOHLENDER CARMEN
权利人:BURDINSKI DIRK; BOHLENDER CARMEN; KONINKL PHILIPS ELECTRONICS NV
摘要:The present invention relates to a method of forming an iron oleate complex comprising the steps of: (a) dissolving an oleate in a low-order alcohol solvent at a temperature of about 35° C. to 65° C.; (b) adding a non-polar solvent to the solution of step (a); (c) adding an iron salt dissolved in a low-order alcohol to the solution of step (b); (d) agitating the solution of step (c) at a temperature of about 50° C. for at least 5 min; (e) cooling the reaction mixture of step (d) to a temperature of about 15° C. to 30° C.; (f) optionally filtering the reaction mixture of step (e); (g) separating the non-polar solvent phase from the low-order alcohol phase; (h) washing and drying the non-polar solvent phase; (i) removing volatiles from the non-polar solvent phase of step (h) by evaporation; and (j) mixing the product of step (i) with a polar solvent to yield a solid iron oleate complex. The present invention further relates to an iron oleate complex obtainable by the method of the invention, an iron oleate complex of formula I, the use of the iron oleate complex of the invention as precursor for the preparation of nanoparticles, and a method of forming iron oxide nanoparticles comprising the suspension of iron oxide/hydroxide and the iron oleate complex of the invention.